UK agency recommends better monitoring of multidrug resistant E coli
BMJ 2005; 331 doi: https://doi.org/10.1136/bmj.331.7517.594 (Published 15 September 2005) Cite this as: BMJ 2005;331:594- Susan Mayor
- London
The Health Protection Agency, the body that monitors and advises on infectious diseases in the United Kingdom, has recommended that monitoring of multidrug resistant Escherichia coli be improved. Its report, published this week, shows a big increase over the past four years in the number of infections associated with the bacterium.
The agency found that the number of infections caused by E colibacteria that produce extended spectrum β lactamase (ESBL) was growing. Extended spectrum β lactamase is an enzyme that hydrolyses and confers resistance to modern cephalosporin antibiotics. The increase has occurred in the …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.